Indoco Remedies Ltd 2018 AR2
The report highlights Indoco Remedies Ltd.'s performance and activities for the fiscal year 2017-2018. Despite challenges such as GST transition and regulatory compliance issues at its Goa plants, the company expanded capacities at its sterile formulation plant in Goa and API unit in Patalganga. Indoco actively contributed to society through its CSR banner 'Sumati Sangopan,' focusing on health, education, and solar energy systems for rural schools. The company also successfully completed USFDA inspections at its Patalganga and Rabale API facilities.
Company: Indoco Remedies Ltd
Sector: Manufacturing
Country: India
Year: 2018
Type: AR2
Pages: 216
Indoco Remedies Ltd
The report highlights Indoco Remedies Ltd.'s performance and activities for the fiscal year 2017-2018. Despite challenges such as GST transition and regulatory compliance issues at its Goa plants, the company expanded capacities at its sterile formulation plant in Goa and API unit in Patalganga. Indoco actively contributed to society through its CSR banner 'Sumati Sangopan,' focusing on health, education, and solar energy systems for rural schools. The company also successfully completed USFDA inspections at its Patalganga and Rabale API facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Apr 1, 2017 - Mar 31, 2018
Fiscal Year
2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees